scispace - formally typeset
A

Alan H. Mutnick

Researcher at University of Iowa

Publications -  19
Citations -  1132

Alan H. Mutnick is an academic researcher from University of Iowa. The author has contributed to research in topics: Quinupristin & Cefepime. The author has an hindex of 14, co-authored 19 publications receiving 1099 citations.

Papers
More filters
Journal ArticleDOI

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).

TL;DR: The results of this study have identified the most common causes of SSTIs in hospitalized patients in North America, and can be used to make informed decisions concerning standards of empiric treatment for S STIs in this region.
Journal ArticleDOI

Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program

TL;DR: Linezolid resistance remains rare, with only 8 isolates among 9833 monitored isolates identified between January 1, 2001, and June 30, 2002, and resistance, however, was no longer limited to enterococci.
Journal ArticleDOI

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).

TL;DR: The SENTRY Antimicrobial Surveillance Program continues to identify important North American patterns of pathogen frequency and resistance and provides comparisons, which function as critical tools for effective patient management and antimicrobial interventions.
Journal ArticleDOI

In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci

TL;DR: BAL9141 demonstrated excellent activity against many tested pathogens displaying various resistance phenotypes, and should be particularly valuable in the treatment of MRSA as well as for drug-resistant streptococci, while maintaining a spectrum resembling a 'third-generation' cephalosporin against other clinically important species.
Journal ArticleDOI

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001)

TL;DR: The availability of aggregate USA medical centre antimicrobial usage data enabled us to identify several important trends in the incidence of resistance among P. aeruginosa and Enterobacteriaceae and require a continued search for other monitoring methods that can better identify antimicrobial/environmental factors that lead to resistance.